Are Endotoxins a Hidden Risk in Pharmaceutical-Grade Lactose?
Pharmaceutical Excipient Safety: Exploring Endotoxin Risks in Lactose : A Perspective from Lactalis Ingredients Pharma At Lactalis Ingredients Pharma, we specialize in milled and sieved pharmaceutical lactose, intended for oral solid dosage forms pharmaceutical applications. While we do not produce lactose for inhalation, the topic of endotoxin risks in pharmaceutical lactose remains highly relevant for […]
U.S. Tariffs: The Geopolitical Shock Reshaping Global Pharma
Trump’s new tariffs and pricing pressures are redrawing the global pharmaceutical map. Discover what’s at stake for innovation, investments, and Europe’s future in drug development.
What Will Shape Pharma in 2026? Key Innovations and Strategic Moves
The pharmaceutical industry continues to evolve under the pressure of medication affordability, regulatory constraints, and growing environmental expectations. In 2025, drug manufacturers face a major challenge: ensuring laboratories profitability while accelerating innovation and industrial performances. Lactalis Ingredients Pharma, as a committed lactose pharmaceutical manufacturer, closely follows these transformations to better support its partners and customers’ […]
Why is lactose still a useful excipient in formulations?
Contrary to popular belief, it is not generally necessary to remove lactose from formulations. The quantities added are extremely small and have no impact on consumers. In pharmaceuticals, lactose is considered as a safe excipient, with limited negative interactions with drugs. A medicine, tablet or capsule, contains between 0,1 g to 0,2 g of lactose, […]
Our CSR commitment recognized by EcoVadis: significant progress between 2024 and 2025
Our 2025 score: 66 pointsProgress: +12 points vs. 2024This change reflects the strengthening of our CSR policy at the Lactalis Group level. How does the EcoVadis rating work? In a context where sustainability and transparency have become strategic criteria, EcoVadis is the international benchmark. Today, more than 150,000 companies in 180 countries rely on […]
Drug Production in France: 3.5 Billion Medicines and a Resilient Healthcare Ecosystem
Explore the evolution of drug production in France and its impact on the healthcare ecosystem, from CDMOs to government initiatives.
Lactalis Ingredients Pharma Is Thrilled to Join CPHI Frankfurt 2025!
Lactalis Ingredients Pharma is delighted to confirm its participation in CPHI Frankfurt 2025, taking place from October 28 to 30 at Messe Frankfurt, Germany. Meet Our Experts at CPHI Frankfurt 2025 Maeva Croué, Nicolas Barachon, Argann Pensec will be on-site to share insights, answer your questions, and guide you through our Lactalpha range of pharmaceutical-grade […]
Which Policies to Support Pharmaceutical Innovation?
At a time of challenges that call for change, it is necessary to place health at the heart of public policy.[1] The importance of pharmaceutical innovation cannot be underestimated, in the interests of public health and the economy alike. By responding to medical needs that are poorly covered or not at all,[2] it offers therapeutic […]
Nitrosamines Contamination in Pharmaceutical Excipients: Risks & Prevention
Nitrosamines, probable human carcinogens, have raised concerns in the pharmaceutical industry. While regulations focus on active ingredients, excipients can also be a source of contamination. Discover the latest detection methods, regulatory updates, and how Lactalis Ingredients Pharma ensures compliance. The Rising Challenge of Nitrosamines Contamination in Excipients Could pharmaceutical excipients be a hidden source of […]
European Pharmaceutical Sovereignty: The Role of Local Excipients
Discover how local excipients like pharmaceutical-grade lactose from Lactalis Ingredients Pharma strengthen European pharmaceutical sovereignty by ensuring reliable, high-quality supply chains. Ensuring European Pharmaceutical Sovereignty: The Key Role of Local Excipients The growing need for pharmaceutical sovereignty has become a critical concern for Europe. Recent supply chain disruptions have exposed vulnerabilities in the availability of […]
